Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

BACKGROUND: Approximately 10% of unselected non-small-cell lung cancer (NSCLC) patients responded to the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment. However, resistance mechanisms are not well understood. We evaluated several potential biological markers of int...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Oncol
Main Authors: Zucali, P.A., Ruiz, M.G., Giovannetti, E., Destro, A., Varella-Garcia, M., Floor, K., Ceresoli, G.L., Rodriguez, J.A., Garassino, I., Comoglio, P., Roncalli, M., Santoro, A., Giaccone, G.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2008
Teme:
lung cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7360138/
https://ncbi.nlm.nih.gov/pubmed/18467317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdn240
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki